The current Phase 2b trial is a double blind.

The current Phase 2b trial is a double blind, randomized, multicenter, non-inferiority, repeat dose study CG100649 compared with celecoxib in OA patients. This is the first time that the effectiveness of the OA CG100649 is tested directly against celecoxib in the same clinical trial. Since CG100649 had high efficacy at 1, study, onlyay in phase shown 2a OA study is assumed that doses of 2 mg / day and 4 mg / day show in the Phase 2b study is that CG100649 is at least comparable with celecoxib with respect to the efficacy. If the initial hypothesis is supported, additional tests examine whether CG100649 celecoxib efficacy compared to celecoxib.

Interaction withtalGenomics Initiates CG100649 Phase 2b study in patients with osteoarthritisCrystalGenomics, Korea) and CG Pharmaceuticals , a biopharmaceutical company with 3 clinical stage candidates, has announced that the first patient has a clinical Phase 2b study of CG100649, CrystalGenomics ‘ clinical stage novel NSAID candidate in patients with knee or hip osteoarthritis were enrolled.Changes to the distribution of Ryan White programs money create financial bottlenecks on Southern California-based AIDS groups, the Riverside Press – Enterprise reports. San Bernardino County, California, health care civil servants be about 7,400 living with HIV / AIDS at San Bernardino and Riverside counties to live.

– David Brinkman, CEO of in Palm Springs, Calif., wilderness AIDS Project , said the organization of saw a 25 percent increase in number of patient to the last 12 months. He added: We are forced to J money] to do, and we are compelled to at our private donor community and do you ask longer. It is an immense burden (Riverside Press – Enterprise.. In December 2006, Congress authorized Ryan White funding in several regions, however enable less money scholarship programs – inclusive food, housing and for legal aid. In addition, Ryan White funding in the last years has been at about $ 2100000000 per year, however view more HIV-positive people enter treatment and longer lives .